Molecular Templates, Inc. Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2018

Accrued liabilities were comprised of the following (in thousands):

	September 30,		December 31,
	2018		2017
Accrued liabilities:
General and administrative	$	848	$	374
Clinical trial related costs		1,441		702
Non-clinical research and manufacturing operations		3,078		435
Payroll related		1,204		1,149
Other accrued expenses		24		30
Total accrued liabilities	$	6,595	$	2,690

Deferred revenue was comprised of the following:

	September 30,		December 31,
	2018		2017
Deferred revenue:
Grant agreements	$	377	$	1,673
Research and development agreements		33,023		1,092
Total deferred revenue	$	33,400	$	2,765